Zhang D, Xue MK, Liu M, Shang XF, Zhang XT
The "Last 20%" thesis of this report is that the marginal clinical territory between the first 15% of weight loss (where semaglutide operates) and the next 10-15% (where Retatrutide and the triple class operate) is precisely the zone where real-world adherence, tolerability, and dose-titration patterns determine how much of the trial number actually reaches patients
84 In the same study, the concept was proven in cancer cell lines by reverting lipid oxidation through the addition of homocysteine
A systematic review explored the role of GLP-1 drugs in managing headaches, particularly migraine and idiopathic intracranial hypertension (IIH)
Field, J., et al., CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
BDYYYB03)